Sudo Biosciences
PrivateLast Round
Series B
Feb 13, 2024
Total Funding Raised
$218M
Company Overview
Sudo Biosciences is a biopharmaceutical company that develops innovative medicines targeting the TYK2 pseudokinase domain to treat immune-mediated inflammatory conditions, including multiple sclerosis and neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sudo Biosciences Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Sudo Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Feb 13, 2024 | ||||
| Series B | Dec 20, 2023 | ||||
| Series A | Sep 28, 2022 | ||||
| Seed | Dec 31, 2020 |
Sudo Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Enavate Sciences | Series B |
| Surveyor Capital | Series B |
| Frazier Healthcare Partners | Series A |
| SV Health Investors | Series B |
| Northern Trust | Series B |
| Eventide Funds | Series B |
| Monograph Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 4, 2025
Paul S. Bavier appointed as Chief Legal Officer.
- Feb 13, 2024
$30M round completed.
Sudo Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Sudo Biosciences's valuation, stock price, and market status.